{"id": "6ebyHtoAAAAJ", "citedby": 7781, "citedby5y": 3615, "hindex": 52, "hindex5y": 33, "i10index": 107, "i10index5y": 84, "coauthors": [], "name": "Christoph Rader", "affiliation": "Professor, The Scripps Research Institute", "interests": ["Antibody Therapeutics", "Antibody Engineering", "Phage Display", "Antibody-Drug Conjugates", "Bispecific Antibodies"], "cites_per_year": {"1996": 53, "1997": 48, "1998": 57, "1999": 66, "2000": 87, "2001": 154, "2002": 118, "2003": 130, "2004": 188, "2005": 183, "2006": 202, "2007": 215, "2008": 216, "2009": 305, "2010": 327, "2011": 361, "2012": 444, "2013": 425, "2014": 465, "2015": 545, "2016": 611, "2017": 674, "2018": 723, "2019": 732, "2020": 318}, "publications": [{"bib": {"title": "Receptor affinity and extracellular domain modifications affect tumor recognition by ROR1-specific chimeric antigen receptor T cells", "year": "2013"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:mB3voiENLucC", "citedby": "314"}, {"bib": {"title": "Phage display of combinatorial antibody libraries", "year": "1997"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:3fE2CSJIrl8C", "citedby": "306"}, {"bib": {"title": "The Nogo-66 receptor homolog NgR2 is a sialic acid-dependent receptor selective for myelin-associated glycoprotein", "year": "2005"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:kNdYIx-mwKoC", "citedby": "264"}, {"bib": {"title": "The nonsignaling extracellular spacer domain of chimeric antigen receptors is decisive for in vivo antitumor activity", "year": "2015"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:70eg2SAEIzsC", "citedby": "248"}, {"bib": {"title": "The B-cell tumor\u2013associated antigen ROR1 can be targeted with T cells modified to express a ROR1-specific chimeric antigen receptor", "year": "2010"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:M3ejUd6NZC8C", "citedby": "233"}, {"bib": {"title": "Methods for the generation of chicken monoclonal antibody fragments by phage display", "year": "2000"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:KlAtU1dfN6UC", "citedby": "233"}, {"bib": {"title": "A phage display approach for rapid antibody humanization: designed combinatorial V gene libraries", "year": "1998"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:ULOm3_A8WrAC", "citedby": "214"}, {"bib": {"title": "Contactin-2/TAG-1-directed autoimmunity is identified in multiple sclerosis patients and mediates gray matter pathology in animals", "year": "2009"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:Zph67rFs4hoC", "citedby": "213"}, {"bib": {"title": "Unique cell surface expression of receptor tyrosine kinase ROR1 in human B-cell chronic lymphocytic leukemia", "year": "2008"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:mVmsd5A6BfQC", "citedby": "206"}, {"bib": {"title": "A novel adoptive transfer model of chronic lymphocytic leukemia suggests a key role for T lymphocytes in the disease", "year": "2011"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:L8Ckcad2t8MC", "citedby": "189"}, {"bib": {"title": "Humanization of murine antibody", "year": "2006"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:XiSMed-E-HIC", "citedby": "179"}, {"bib": {"title": "Rabbit immune repertoires as sources for therapeutic monoclonal antibodies: the impact of kappa allotype-correlated variation in cysteine content on antibody libraries selected \u2026", "year": "2003"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:9ZlFYXVOiuMC", "citedby": "148"}, {"bib": {"title": "Multiple event activation of a generic prodrug trigger by antibody catalysis", "year": "1999"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:YOwf2qJgpHMC", "citedby": "147"}, {"bib": {"title": "Lenalidomide treatment promotes CD154 expression on CLL cells and enhances production of antibodies by normal B cells through a PI3-kinase\u2013dependent pathway", "year": "2010"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:aqlVkmm33-oC", "citedby": "141"}, {"bib": {"title": "The axonally secreted cell adhesion molecule, axonin\u20101: primary structure, immunoglobulin\u2010like and fibronectin\u2010type\u2010III\u2010like domains and glycosyl\u2010phosphatidylinositol anchorage", "year": "1992"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:4TOpqqG69KYC", "citedby": "137"}, {"bib": {"title": "The rabbit antibody repertoire as a novel source for the generation of therapeutic human antibodies", "year": "2000"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:qxL8FJ1GzNcC", "citedby": "132"}, {"bib": {"title": "Cell adhesion molecules NgCAM and axonin-1 form heterodimers in the neuronal membrane and cooperate in neurite outgrowth promotion.", "year": "1996"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:_kc_bZDykSQC", "citedby": "127"}, {"bib": {"title": "Implications of the HIV-1 Rev dimer structure at 3.2 \u00c5 resolution for multimeric binding to the Rev response element", "year": "2010"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:hFOr9nPyWt4C", "citedby": "122"}, {"bib": {"title": "In vivo activity in a catalytic antibody-prodrug system: antibody catalyzed etoposide prodrug activation for selective chemotherapy", "year": "2001"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:4DMP91E08xMC", "citedby": "121"}, {"bib": {"title": "Neurite fasciculation mediated by complexes of axonin-1 and Ng cell adhesion molecule", "year": "1998"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:Wp0gIr-vW9MC", "citedby": "111"}, {"bib": {"title": "Bortezomib resistance in mantle cell lymphoma is associated with plasmacytic differentiation", "year": "2011"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:HDshCWvjkbEC", "citedby": "102"}, {"bib": {"title": "Mechanisms of CNS myelin inhibition: evidence for distinct and neuronal cell type specific receptor systems", "year": "2008"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:7PzlFSSx8tAC", "citedby": "101"}, {"bib": {"title": "Safety of targeting ROR1 in primates with chimeric antigen receptor\u2013modified T cells", "year": "2015"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:b0M2c_1WBrUC", "citedby": "100"}, {"bib": {"title": "Phenotypic knockout of VEGF-R2 and Tie-2 with an intradiabody reduces tumor growth and angiogenesis in vivo", "year": "2005"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:ZeXyd9-uunAC", "citedby": "100"}, {"bib": {"title": "Molecularly defined antibody conjugation through a selenocysteine interface", "year": "2009"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:bEWYMUwI8FkC", "citedby": "96"}, {"bib": {"title": "A direct interaction of axonin-1 with NgCAM-related cell adhesion molecule (NrCAM) results in guidance, but not growth of commissural axons", "year": "2000"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:QIV2ME_5wuYC", "citedby": "95"}, {"bib": {"title": "Chemically programmed monoclonal antibodies for cancer therapy: adaptor immunotherapy based on a covalent antibody catalyst", "year": "2003"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:-f6ydRqryjwC", "citedby": "93"}, {"bib": {"title": "Cell\u2010cell adhesion by homophilic interaction of the neuronal recognition molecule axonin\u20101", "year": "1993"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:dhFuZR0502QC", "citedby": "90"}, {"bib": {"title": "Therapeutic potential and challenges of targeting receptor tyrosine kinase ROR1 with monoclonal antibodies in B-cell malignancies", "year": "2011"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:JV2RwH3_ST0C", "citedby": "88"}, {"bib": {"title": "Targeting tumor angiogenesis with adenovirus-delivered anti-Tie-2 intrabody", "year": "2005"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:IWHjjKOFINEC", "citedby": "87"}, {"bib": {"title": "Intradiabodies, bispecific, tetravalent antibodies for the simultaneous functional knockout of two cell surface receptors", "year": "2003"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:TQgYirikUcIC", "citedby": "87"}, {"bib": {"title": "Generation and characterization of a recombinant human ccr5-specific antibody a phage display approach for rabbit antibody humanization", "year": "2000"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:hC7cP41nSMkC", "citedby": "80"}, {"bib": {"title": "An engineered selenocysteine defines a unique class of antibody derivatives", "year": "2008"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:r0BpntZqJG4C", "citedby": "76"}, {"bib": {"title": "Isolation of human prostate cancer cell reactive antibodies using phage display technology", "year": "2004"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:e5wmG9Sq2KIC", "citedby": "76"}, {"bib": {"title": "A chemical adaptor system designed to link a tumor\u2010targeting device with a prodrug and an enzymatic trigger", "year": "2003"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:_Qo2XoVZTnwC", "citedby": "76"}, {"bib": {"title": "Implications for the domain arrangement of axonin\u20101 derived from the mapping of its NgCAM binding site.", "year": "1996"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:qUcmZB5y_30C", "citedby": "75"}, {"bib": {"title": "Mining human antibody repertoires", "year": "2010"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:vV6vV6tmYwMC", "citedby": "71"}, {"bib": {"title": "Improving the serum stability of site-specific antibody conjugates with sulfone linkers", "year": "2014"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:4OULZ7Gr8RgC", "citedby": "70"}, {"bib": {"title": "A humanized aldolase antibody for selective chemotherapy and adaptor immunotherapy", "year": "2003"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:4JMBOYKVnBMC", "citedby": "67"}, {"bib": {"title": "A33 antigen specific immunoglobulin products and uses thereof", "year": "2002"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:WbkHhVStYXYC", "citedby": "66"}, {"bib": {"title": "Integrin \u03b1v\u03b23 targeted therapy for Kaposi\u2019s sarcoma with an in vitro evolved antibody", "year": "2002"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:R3hNpaxXUhUC", "citedby": "64"}, {"bib": {"title": "Targeting malignant B cells with an immunotoxin against ROR1", "year": "2012"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:J_g5lzvAfSwC", "citedby": "63"}, {"bib": {"title": "Molecular basis of the interactions of the Nogo-66 receptor and its homolog NgR2 with myelin-associated glycoprotein: development of NgROMNI-Fc, a novel antagonist of CNS \u2026", "year": "2009"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:j3f4tGmQtD8C", "citedby": "59"}, {"bib": {"title": "Clinical development of a poly (2-oxazoline)(POZ) polymer therapeutic for the treatment of Parkinson\u2019s disease\u2013Proof of concept of POZ as a versatile polymer platform for drug \u2026", "year": "2017"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:eq2jaN3J8jMC", "citedby": "58"}, {"bib": {"title": "Using antibody catalysis to study the outcome of multiple evolutionary trials of a chemical task", "year": "2000"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:RHpTSmoSYBkC", "citedby": "56"}, {"bib": {"title": "cDNA cloning, structural features, and eucaryotic expression of human TAG\u20101/axonin\u20101", "year": "1993"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:isC4tDSrTZIC", "citedby": "54"}, {"bib": {"title": "A novel high\u2010affinity human monoclonal antibody to mesothelin", "year": "2011"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:hMod-77fHWUC", "citedby": "53"}, {"bib": {"title": "DARTs take aim at BiTEs", "year": "2011"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:D03iK_w7-QYC", "citedby": "53"}, {"bib": {"title": "Human/mouse cross-reactive anti-VEGF receptor 2 recombinant antibodies selected from an immune b9 allotype rabbit antibody library", "year": "2004"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:M3NEmzRMIkIC", "citedby": "53"}, {"bib": {"title": "Prodrug activation using catalytic antibodies", "year": "2001"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:l7t_Zn2s7bgC", "citedby": "53"}, {"bib": {"title": "Synthesis of the next-generation therapeutic antibodies that combine cell targeting and antibody-catalyzed prodrug activation", "year": "2007"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:TFP_iSt0sucC", "citedby": "52"}, {"bib": {"title": "Chemical adaptor immunotherapy: design, synthesis, and evaluation of novel integrin-targeting devices", "year": "2004"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:iH-uZ7U-co4C", "citedby": "52"}, {"bib": {"title": "Axonin-1/TAG-1 mediates cell-cell adhesion by a cis-assisted trans-interaction", "year": "2002"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:blknAaTinKkC", "citedby": "50"}, {"bib": {"title": "Antibody libraries in drug and target discovery", "year": "2001"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:k_IJM867U9cC", "citedby": "47"}, {"bib": {"title": "Restricted cell surface expression of receptor tyrosine kinase ROR1 in pediatric B-lineage acute lymphoblastic leukemia suggests targetability with therapeutic monoclonal \u2026", "year": "2012"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:fPk4N6BV_jEC", "citedby": "46"}, {"bib": {"title": "Small molecule drug activity in melanoma models may be dramatically enhanced with an antibody effector", "year": "2006"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:NMxIlDl6LWMC", "citedby": "44"}, {"bib": {"title": "Chimeric rabbit/human Fab and IgG specific for members of the Nogo-66 receptor family selected for species cross-reactivity with an improved phage display vector", "year": "2007"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:GnPB-g6toBAC", "citedby": "43"}, {"bib": {"title": "IGF1R-and ROR1-specific CAR T cells as a potential therapy for high risk sarcomas", "year": "2015"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:eQOLeE2rZwMC", "citedby": "42"}, {"bib": {"title": "Chemically programmed antibodies", "year": "2014"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:SeFeTyx0c_EC", "citedby": "40"}, {"bib": {"title": "Strain prioritization and genome mining for enediyne natural products", "year": "2016"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:WqliGbK-hY8C", "citedby": "38"}, {"bib": {"title": "Generation, affinity maturation, and characterization of a human anti-human NKG2D monoclonal antibody with dual antagonistic and agonistic activity", "year": "2008"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:NaGl4SEjCO4C", "citedby": "38"}, {"bib": {"title": "Site-specific dual antibody conjugation via engineered cysteine and selenocysteine residues", "year": "2015"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:Y0pCki6q_DkC", "citedby": "37"}, {"bib": {"title": "Antibody conjugation via one and two C-terminal selenocysteines", "year": "2014"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:pqnbT2bcN3wC", "citedby": "37"}, {"bib": {"title": "Harnessing a catalytic lysine residue for the one-step preparation of homogeneous antibody-drug conjugates", "year": "2017"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:xtoqd-5pKcoC", "citedby": "36"}, {"bib": {"title": "Application of strain-promoted azide\u2013alkyne cycloaddition and tetrazine ligation to targeted Fc-drug conjugates", "year": "2012"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:M05iB0D1s5AC", "citedby": "35"}, {"bib": {"title": "E. coli Expression and Purification of Fab Antibody Fragments", "year": "2009"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:g5m5HwL7SMYC", "citedby": "35"}, {"bib": {"title": "Prodrugs of dynemicin analogs for selective chemotherapy mediated by an aldolase catalytic Ab", "year": "2004"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:YFjsv_pBGBYC", "citedby": "35"}, {"bib": {"title": "From rabbit antibody repertoires to rabbit monoclonal antibodies", "year": "2017"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:VaXvl8Fpj5cC", "citedby": "34"}, {"bib": {"title": "Generation of human scFv antibody libraries: PCR amplification and assembly of light-and heavy-chain coding sequences", "year": "2011"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:maZDTaKrznsC", "citedby": "33"}, {"bib": {"title": "New chemical adaptor unit designed to release a drug from a tumor targeting device by enzymatic triggering", "year": "2004"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:lSLTfruPkqcC", "citedby": "33"}, {"bib": {"title": "Prodrug activation using catalytic antibodies", "year": "2004"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:YohjEiUPhakC", "citedby": "31"}, {"bib": {"title": "Tumor antigen ROR1 targeted drug delivery mediated selective leukemic but not normal B-cell cytotoxicity in chronic lymphocytic leukemia", "year": "2015"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:abG-DnoFyZgC", "citedby": "30"}, {"bib": {"title": "Catalytic antibodies as magic bullets.", "year": "2000"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:O3NaXMp0MMsC", "citedby": "29"}, {"bib": {"title": "Integrin \u03b1IIb\u03b23-specific synthetic human monoclonal antibodies and HCDR3 peptides that potently inhibit platelet aggregation", "year": "2004"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:ns9cj8rnVeAC", "citedby": "28"}, {"bib": {"title": "The gene of chicken axonin\u20101: Complete structure and analysis of the promoter", "year": "1995"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:BqipwSGYUEgC", "citedby": "28"}, {"bib": {"title": "Generation and characterization of a chimeric rabbit/human Fab for co-crystallization of HIV-1 Rev", "year": "2010"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:ldfaerwXgEUC", "citedby": "26"}, {"bib": {"title": "Logic-gated ROR1 chimeric antigen receptor expression rescues T cell-mediated toxicity to normal tissues and enables selective tumor targeting", "year": "2019"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:mNrWkgRL2YcC", "citedby": "25"}, {"bib": {"title": "Genome Mining of Micromonospora yangpuensis DSM 45577 as a Producer of an Anthraquinone-Fused Enediyne", "year": "2017"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:HbR8gkJAVGIC", "citedby": "24"}, {"bib": {"title": "Chemically programmed bispecific antibodies in diabody format", "year": "2016"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:Y5dfb0dijaUC", "citedby": "24"}, {"bib": {"title": "Chemically programmed bispecific antibodies that recruit and activate T cells", "year": "2012"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:zA6iFVUQeVQC", "citedby": "24"}, {"bib": {"title": "Generation and selection of rabbit antibody libraries by phage display", "year": "2009"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:u_35RYKgDlwC", "citedby": "24"}, {"bib": {"title": "The contactin-related protein FAR-2 defines Purkinje cell clusters and labels subpopulations of climbing fibers in the developing cerebellum", "year": "2001"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:RGFaLdJalmkC", "citedby": "24"}, {"bib": {"title": "Potent and selective antitumor activity of a T cell-engaging bispecific antibody targeting a membrane-proximal epitope of ROR1", "year": "2018"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:foquWX3nUaYC", "citedby": "23"}, {"bib": {"title": "Generation of human scFv antibody libraries: PCR amplification and assembly of light-and heavy-chain coding sequences", "year": "2011"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:dfsIfKJdRG4C", "citedby": "23"}, {"bib": {"title": "Overview on concepts and applications of Fab antibody fragments", "year": "2009"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:2P1L_qKh6hAC", "citedby": "23"}, {"bib": {"title": "A CD19/CD3 bispecific antibody for effective immunotherapy of chronic lymphocytic leukemia in the ibrutinib era", "year": "2018"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:_axFR9aDTf0C", "citedby": "22"}, {"bib": {"title": "Fully human anti-human NKG2D monoclonal antibodies", "year": "2016"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:V3AGJWp-ZtQC", "citedby": "22"}, {"bib": {"title": "Angucyclines and Angucyclinones from Streptomyces sp. CB01913 Featuring C-Ring Cleavage and Expansion", "year": "2015"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:VOx2b1Wkg3QC", "citedby": "22"}, {"bib": {"title": "Mining naive rabbit antibody repertoires by phage display for monoclonal antibodies of therapeutic utility", "year": "2017"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:i2xiXl-TujoC", "citedby": "20"}, {"bib": {"title": "The New Zealand black mouse as a model for the development and progression of chronic lymphocytic leukemia", "year": "2010"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:rO6llkc54NcC", "citedby": "20"}, {"bib": {"title": "A human monoclonal antibody drug and target discovery platform for B-cell chronic lymphocytic leukemia based on allogeneic hematopoietic stem cell transplantation and phage display", "year": "2009"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:HoB7MX3m0LUC", "citedby": "18"}, {"bib": {"title": "Antibody targeting compounds", "year": "2012"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:JoZmwDi-zQgC", "citedby": "16"}, {"bib": {"title": "Recognition of antigen-specific B-cell receptors from chronic lymphocytic leukemia patients by synthetic antigen surrogates", "year": "2014"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:P5F9QuxV20EC", "citedby": "15"}, {"bib": {"title": "Stable and potent selenomab-drug conjugates", "year": "2017"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:LI9QrySNdTsC", "citedby": "14"}, {"bib": {"title": "Antibody targeting compounds", "year": "2003"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:-FonjvnnhkoC", "citedby": "14"}, {"bib": {"title": "Discrete clusters of axonin-1 and NgCAM at neuronal contact sites: facts and speculations on the regulation of axonal fasciculation", "year": "1998"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:3s1wT3WcHBgC", "citedby": "14"}, {"bib": {"title": "Harnessing the Fc\u03bc receptor for potent and selective cytotoxic therapy of chronic lymphocytic leukemia", "year": "2014"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:ufrVoPGSRksC", "citedby": "13"}, {"bib": {"title": "Generation of human Fab libraries for phage display", "year": "2012"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:xtRiw3GOFMkC", "citedby": "13"}, {"bib": {"title": "Assessment of reagents for selenocysteine conjugation and the stability of selenocysteine adducts", "year": "2016"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:t6usbXjVLHcC", "citedby": "12"}, {"bib": {"title": "Chemical biology: how to minimalize antibodies", "year": "2015"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:roLk4NBRz8UC", "citedby": "12"}, {"bib": {"title": "Targeting compounds", "year": "2013"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:b1wdh0AR-JQC", "citedby": "12"}, {"bib": {"title": "Aldolase Antibody Activation of Prodrugs of Potent Aldehyde\u2010Containing Cytotoxics for Selective Chemotherapy", "year": "2004"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:yD5IFk8b50cC", "citedby": "12"}, {"bib": {"title": "Dendritic cells; methods", "year": "2003"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:_FM0Bhl9EiAC", "citedby": "12"}, {"bib": {"title": "ROR1-targeted delivery of OSU-2S, a nonimmunosuppressive FTY720 derivative, exerts potent cytotoxicity in mantle-cell lymphoma in vitro and in vivo", "year": "2015"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:u-x6o8ySG0sC", "citedby": "11"}, {"bib": {"title": "Lipid-directed vinculin dimerization", "year": "2015"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:hqOjcs7Dif8C", "citedby": "11"}, {"bib": {"title": "Neutralization of Burkholderia pseudomallei Protease by Fabs Generated through Phage Display", "year": "2005"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:a0OBvERweLwC", "citedby": "11"}, {"bib": {"title": "From catalytic asymmetric synthesis to the transcriptional regulation of genes: in vivo and in vitro evolution of proteins", "year": "2001"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:cFHS6HbyZ2cC", "citedby": "11"}, {"bib": {"title": "Application of a trifunctional reactive linker for the construction of antibody\u2013drug hybrid conjugates", "year": "2008"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:EUQCXRtRnyEC", "citedby": "10"}, {"bib": {"title": "Comparative studies of the biosynthetic gene clusters for anthraquinone-fused enediynes shedding light into the tailoring steps of tiancimycin biosynthesis", "year": "2018"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:0izLItjtcgwC", "citedby": "9"}, {"bib": {"title": "Anti-human ROR1 antibodies", "year": "2016"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:1qzjygNMrQYC", "citedby": "9"}, {"bib": {"title": "The nonsignaling extracellular spacer domain of chimeric antigen receptors is decisive for in vivo antitumor a ctivity.", "year": "2015"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:nZcligLrVowC", "citedby": "9"}, {"bib": {"title": "Selection of Human Fab Libraries by Phage Display", "year": "2012"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:p2g8aNsByqUC", "citedby": "8"}, {"bib": {"title": "Integrin targeting compounds", "year": "2003"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:ZuybSZzF8UAC", "citedby": "8"}, {"bib": {"title": "Methods for reducing the effects of cancers that express A33 antigen using A33 antigen specific immunoglobulin products", "year": "2002"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:tOudhMTPpwUC", "citedby": "8"}, {"bib": {"title": "Chimeric antigen receptor library screening using a novel NF-\u03baB/NFAT reporter cell platform", "year": "2019"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:a9-T7VOCCH8C", "citedby": "7"}, {"bib": {"title": "CAR T cells targeting \u03b1v\u03b23 integrin are effective against advanced cancer in preclinical models", "year": "2018"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:9pM33mqn1YgC", "citedby": "7"}, {"bib": {"title": "Engineered production of cancer targeting peptide (CTP)-containing C-1027 in Streptomyces globisporus and biological evaluation", "year": "2016"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:bnK-pcrLprsC", "citedby": "7"}, {"bib": {"title": "Targeting stereotyped B cell receptors from chronic lymphocytic leukemia patients with synthetic antigen surrogates", "year": "2016"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:mvPsJ3kp5DgC", "citedby": "7"}, {"bib": {"title": "Method for the treatment of obesity", "year": "2015"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:BrmTIyaxlBUC", "citedby": "7"}, {"bib": {"title": "On-Water Silver (I)-Catalyzed Cycloisomerization of Acetylenic Free Amines/Amides towards 7-Azaindole/Indole/Isoquinolone Derivatives", "year": "2017"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:S16KYo8Pm5AC", "citedby": "6"}, {"bib": {"title": "Human serum albumin domain I fusion protein for antibody conjugation", "year": "2016"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:SdhP9T11ey4C", "citedby": "6"}, {"bib": {"title": "Selenocysteine mediated hybrid antibody molecules", "year": "2014"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:4fKUyHm3Qg0C", "citedby": "6"}, {"bib": {"title": "Simultaneous, phenotypic knockout of VEGF-R2 and Tie-2 with an intradiabody enhances antiangiogenic effects in vivo", "year": "2006"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:eMMeJKvmdy0C", "citedby": "6"}, {"bib": {"title": "Site-selective antibody functionalization via orthogonally reactive arginine and lysine residues", "year": "2019"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:bKqednn6t2AC", "citedby": "5"}, {"bib": {"title": "Rabbit models of human diseases for diagnostics and therapeutics development", "year": "2019"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:NXb4pA-qfm4C", "citedby": "5"}, {"bib": {"title": "Tagging the untaggable: a difluoroalkyl-sulfinate ketone-based reagent for direct C\u2013H functionalization of bioactive heteroarenes", "year": "2016"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:dTyEYWd-f8wC", "citedby": "5"}, {"bib": {"title": "Cloning, expression, and purification of monoclonal antibodies in scFv-Fc format", "year": "2012"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:UebtZRa9Y70C", "citedby": "5"}, {"bib": {"title": "Site-Specific Lysine Arylation as an Alternative Bioconjugation Strategy for Chemically Programmed Antibodies and Antibody\u2013Drug Conjugates", "year": "2019"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:a3BOlSfXSfwC", "citedby": "4"}, {"bib": {"title": "Abstract P2-09-13: A phase I study of adoptive immunotherapy for ROR1+ advanced triple negative breast cancer (TNBC) with defined subsets of autologous T cells expressing a \u2026", "year": "2019"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:HIFyuExEbWQC", "citedby": "4"}, {"bib": {"title": "Engineering Dual Variable Domains for the Generation of Site-Specific Antibody\u2013Drug Conjugates", "year": "2019"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:OR75R8vi5nAC", "citedby": "4"}, {"bib": {"title": "Abstract CT131: A phase I study of adoptive immunotherapy for advanced ROR1+ malignancies with defined subsets of autologous T cells expressing a ROR1-specific chimeric antigen \u2026", "year": "2018"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:bz8QjSJIRt4C", "citedby": "4"}, {"bib": {"title": "Siglec-6 on chronic lymphocytic leukemia cells is a target for post-allogeneic hematopoietic stem cell transplantation antibodies", "year": "2018"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:4fGpz3EwCPoC", "citedby": "4"}, {"bib": {"title": "Chimeric rabbit/human ROR1 antibodies", "year": "2017"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:wbdj-CoPYUoC", "citedby": "4"}, {"bib": {"title": "Selection of apoptotic cell specific human antibodies from adult bone marrow", "year": "2014"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:SP6oXDckpogC", "citedby": "4"}, {"bib": {"title": "Analysis of Cell\u2010Cell Contact Mediated by Ig Superfamily Cell Adhesion Molecules", "year": "2013"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:u9iWguZQMMsC", "citedby": "4"}, {"bib": {"title": "Elevated BAFF is correlated with inflammatory processes in chronic graft versus host disease and supports increases in transitional B cells", "year": "2008"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:N5tVd3kTz84C", "citedby": "4"}, {"bib": {"title": "Targeting human B cell chronic lymphocytic leukemia with a monoclonal antibody specific for the Receptor Tyrosine Kinase ROR1", "year": "2008"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:PR6Y55bgFSsC", "citedby": "4"}, {"bib": {"title": "Dual-mechanistic antibody-drug conjugate via site-specific selenocysteine/cysteine conjugation", "year": "2019"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:yqoGN6RLRZoC", "citedby": "3"}, {"bib": {"title": "An IgG1-like bispecific antibody targeting CD52 and CD20 for the treatment of B-cell malignancies", "year": "2019"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:8d8msizDQcsC", "citedby": "3"}, {"bib": {"title": "Conventional and chemically programmed asymmetric bispecific antibodies targeting folate receptor 1", "year": "2019"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:3htObqc8RwsC", "citedby": "3"}, {"bib": {"title": "A Sortase A programmable phage display format for improved panning of Fab antibody libraries", "year": "2018"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:LO7wyVUgiFcC", "citedby": "3"}, {"bib": {"title": "Cyclic peptide conjugates and methods of use", "year": "2018"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:9vf0nzSNQJEC", "citedby": "3"}, {"bib": {"title": "Chimeric rabbit/human Fab antibodies against the hepatitis Be-antigen and their potential applications in assays, characterization, and therapy", "year": "2017"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:SpbeaW3--B0C", "citedby": "3"}, {"bib": {"title": "Utilization of selenocysteine for site-specific antibody conjugation", "year": "2017"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:lmc2jWPfTJgC", "citedby": "3"}, {"bib": {"title": "Naive CD4+ T cells modified to express a ROR1-specific CAR mediate anti-tumor activity and provide superior help to CD8+ ROR1-CAR T cells", "year": "2011"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:HE397vMXCloC", "citedby": "3"}, {"bib": {"title": "Monoclonal antibody therapy for cancer", "year": "2011"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:CHSYGLWDkRkC", "citedby": "3"}, {"bib": {"title": "Reinforced steel beam and hybrid joist", "year": "2003"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:FAceZFleit8C", "citedby": "3"}, {"bib": {"title": "PROTEIN SYNTHESIS, POST-TRANSLATION MODIFICATION, AND DEGRADATION-Intradiabodies, Bispecific, Tetravalent Antibodies for the Simultaneous Functional Knockout of Two Cell \u2026", "year": "2003"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:UHK10RUVsp4C", "citedby": "3"}, {"bib": {"title": "Tumor antigen ROR1 targeted delivery of miR-29b in chronic lymphocytic leukemia induces epigenetic reprograming resulting in cell cycle arrest", "year": "2017"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:Ug5p-4gJ2f0C", "citedby": "2"}, {"bib": {"title": "GDNF family receptor alpha 4 (GFRa4)-targeted adoptive T-cell immunotherapy for medullary thyroid carcinoma", "year": "2016"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:Fu2w8maKXqMC", "citedby": "2"}, {"bib": {"title": "Carlos F. Barbas III (1964\u20132014): Visionary at the Interface of Chemistry and Biology", "year": "2014"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:u5HHmVD_uO8C", "citedby": "2"}, {"bib": {"title": "A human monoclonal antibody and antigen discovery platform based on allogeneic hematopoietic stem cell transplantation and phage display", "year": "2008"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:hkOj_22Ku90C", "citedby": "2"}, {"bib": {"title": "Monoclonal antibodies in cancer therapy", "year": "2007"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:UxriW0iASnsC", "citedby": "2"}, {"bib": {"title": "Receptor tyrosine kinase-like orphan receptor 1 (ROR1) as a potential target antigen for immunotherapy of human B cell chronic lymphocytic leukemia", "year": "2006"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:1yQoGdGgb4wC", "citedby": "2"}, {"bib": {"title": "Analysis of Cell\u2010Cell Contact Mediated by Ig Superfamily Cell Adhesion Molecules", "year": "2001"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:1sJd4Hv_s6UC", "citedby": "2"}, {"bib": {"title": "Structural features of neural immunoglobulin superfamily adhesion molecules", "year": "1999"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:KxtntwgDAa4C", "citedby": "2"}, {"bib": {"title": "Bispecific antibodies in cancer immunotherapy", "year": "2020"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:8xutWZnSdmoC", "citedby": "1"}, {"bib": {"title": "Six-packed antibodies punch better", "year": "2019"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:yMeIxYmEMEAC", "citedby": "1"}, {"bib": {"title": "ROR1-targeted delivery of miR-29b induces cell cycle arrest and therapeutic benefit in vivo in a CLL mouse model", "year": "2019"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:DJbcl8HfkQkC", "citedby": "1"}, {"bib": {"title": "\" One, if by land, and two, if by sea\": bispecific antibodies join the revolution.", "year": "2019"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:XvxMoLDsR5gC", "citedby": "1"}, {"bib": {"title": "Antibody targeting cell surface deposited complement protein C3d and use thereof", "year": "2018"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:5awf1xo2G04C", "citedby": "1"}, {"bib": {"title": "Evaluation of ROR1 targeted antibody drug conjugates in acute and chronic lymphocytic leukemia and mantle cell lymphoma", "year": "2017"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:edDO8Oi4QzsC", "citedby": "1"}, {"bib": {"title": "Activity of CD19/CD3 bispecific antibodies in chronic lymphocytic leukemia", "year": "2017"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:XoXfffV-tXoC", "citedby": "1"}, {"bib": {"title": "Chemical Assembly of Antibody-Drug Conjugates", "year": "2017"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:kz9GbA2Ns4gC", "citedby": "1"}, {"bib": {"title": "Site-Specific Antibody\u2013Drug Conjugates in Triple Variable Domain Fab Format", "year": "2020"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:fbc8zXXH2BUC", "citedby": "0"}, {"bib": {"title": "Affinity maturation, humanization, and co-crystallization of a rabbit anti-human ROR2 monoclonal antibody for therapeutic applications", "year": "2020"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:_OXeSy2IsFwC", "citedby": "0"}, {"bib": {"title": "Generation and validation of structurally defined antibody\u2013siRNA conjugates", "year": "2020"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:Aul-kAQHnToC", "citedby": "0"}, {"bib": {"title": "Chemically programmable and switchable CAR\u2010T therapy", "year": "2020"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:ZzlSgRqYykMC", "citedby": "0"}, {"bib": {"title": "ROR1 antibody compositions and related methods", "year": "2020"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:4hFrxpcac9AC", "citedby": "0"}, {"bib": {"title": "ROR1 Targeted Immunoliposomal Delivery of OSU-2S Show Selective Cytotoxicity in t (1; 19) Translocated B-ALL", "year": "2019"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:OP4eGU-M3BUC", "citedby": "0"}, {"bib": {"title": "A CD19/CD3 Bispecific Antibody Induces Superior T Cell Responses Against Chronic Lymphocytic Leukemia When Combined with Ibrutinib", "year": "2019"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:F9fV5C73w3QC", "citedby": "0"}, {"bib": {"title": "Evaluation of ROR1 targeted antibody drug conjugate in ROR1 positive leukemia", "year": "2019"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:ODE9OILHJdcC", "citedby": "0"}, {"bib": {"title": "Discovery and diversification of tiancimycin (TMN) natural products for Antibody Drug Conjugates (ADCs)", "year": "2019"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:KbBQZpvPDL4C", "citedby": "0"}, {"bib": {"title": "Cyclic peptide conjugates and methods of use", "year": "2019"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:cWzG1nlazyYC", "citedby": "0"}, {"bib": {"title": "ANTIBODY TARGETING CELL SURFACE DEPOSITED COMPLEMENT PROTEIN C3d AND USE THEREOF", "year": "2019"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:4vMrXwiscB8C", "citedby": "0"}, {"bib": {"title": "Ror2 antibody compositions and related methods", "year": "2019"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:umqufdRvDiIC", "citedby": "0"}, {"bib": {"title": "Dual variable domain immunoconjugates and uses thereof", "year": "2018"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:anf4URPfarAC", "citedby": "0"}, {"bib": {"title": "CAR-T cells targeting alpha (v) beta (3) integrin confer complete remission of epithelial cancers in pre-clinical models in vivo", "year": "2018"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:r_AWSJRzSzQC", "citedby": "0"}, {"bib": {"title": "A Reporter Cell Platform for High-Throughput Screening of Chimeric Antigen Receptor (CAR) Libraries", "year": "2018"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:GtLg2Ama23sC", "citedby": "0"}, {"bib": {"title": "Chimeric rabbit/human ror1 antibodies", "year": "2018"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:PVjk1bu6vJQC", "citedby": "0"}, {"bib": {"title": "CAR T cells targeting \u03b1v\u00df3 integrin are effective against advanced cancer in preclinical models.", "year": "2018"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:u-coK7KVo8oC", "citedby": "0"}, {"bib": {"title": "Safety and antitumor efficacy of ROR2-specific CAR T cells in pre-clinical models", "year": "2018"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:HtEfBTGE9r8C", "citedby": "0"}, {"bib": {"title": "ROR2 is a novel target for CAR T cells in breast cancer", "year": "2017"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:Dip1O2bNi0gC", "citedby": "0"}, {"bib": {"title": "Harnessing a catalytic lysine residue for the rapid, one-step preparation of homogeneous antibody-drug conjugates", "year": "2017"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:86PQX7AUzd4C", "citedby": "0"}, {"bib": {"title": "Tunable Drug Conjugates: a differentiated drug conjugate (DC) platform", "year": "2017"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:e_rmSamDkqQC", "citedby": "0"}, {"bib": {"title": "CD19/CD3 bispecific antibodies induce potent response against chronic lymphocytic leukemia cells ex vivo", "year": "2017"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:M7yex6snE4oC", "citedby": "0"}, {"bib": {"title": "Potentiating immunotherapy by targeting complement deposited on cancer cell surfaces", "year": "2016"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:AvfA0Oy_GE0C", "citedby": "0"}, {"bib": {"title": "Method for the treatment of obesity", "year": "2016"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:XiVPGOgt02cC", "citedby": "0"}, {"bib": {"title": "Even Walseng, Christopher G. Nelson, Junpeng Qi, Alex R. Nanna, William R. Roush, Rajib", "year": "2016"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:PoWvk5oyLR8C", "citedby": "0"}, {"bib": {"title": "Immunoliposomal Delivery of Mir-29b By Targeting Tumor Antigen ROR1 Induces Epigenetic Reprograming in Human-ROR1-Expressed Mouse Model of Chronic Lymphocytic Leukemia", "year": "2015"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:9Nmd_mFXekcC", "citedby": "0"}, {"bib": {"title": "Monoclonal antibodies targeting cell surface deposited complement fragment C3d potentiate cancer immunotherapy and eliminate antigen loss variants", "year": "2015"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:BUYA1_V_uYcC", "citedby": "0"}, {"bib": {"title": "Targeting deposited complement component C3d to potentiate monoclonal antibody cancer therapy (VAC3P. 1057)", "year": "2015"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:XD-gHx7UXLsC", "citedby": "0"}, {"bib": {"title": "Selenocysteine mediated hybrid antibody molecules", "year": "2015"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:rmuvC79q63oC", "citedby": "0"}, {"bib": {"title": "IGF1R-and ROR1-Specific Chimeric Antigen Receptor (CAR) T Cell Immunotherapy for Poor Risk Sarcomas", "year": "2015"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:hMsQuOkrut0C", "citedby": "0"}, {"bib": {"title": "Safety of targeting ROR1 for cancer immunotherapy with chimeric antigen receptor-modified T cells in a primate model", "year": "2014"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:ML0RJ9NH7IQC", "citedby": "0"}, {"bib": {"title": "B cell surface reactive antibodies", "year": "2014"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:kh2fBNsKQNwC", "citedby": "0"}, {"bib": {"title": "B cell surface reactive antibodies", "year": "2014"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:Se3iqnhoufwC", "citedby": "0"}, {"bib": {"title": "Novel IgM-derived antibody-drug conjugate selectively kills chronic lymphocytic leukemia cells through binding of Fc\u03bc-receptor leading to rapid internalization and \u2026", "year": "2014"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:NJ774b8OgUMC", "citedby": "0"}, {"bib": {"title": "Chimeric Antigen Receptor (CAR) T Cell Immunotherapy for Poor Risk Sarcomas", "year": "2014"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:ZfRJV9d4-WMC", "citedby": "0"}, {"bib": {"title": "Acknowledgement to Reviewers of Antibodies in 2013", "year": "2014"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:VLnqNzywnoUC", "citedby": "0"}, {"bib": {"title": "Tumor Antigen ROR1 Targeted Delivery Of FTY720 Derivative OSU-2S Prolongs Survival In ROR1 Engineered Mouse Model Of Chronic Lymphocytic Leukemia", "year": "2013"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:TIZ-Mc8IlK0C", "citedby": "0"}, {"bib": {"title": "Targeting the Fc\u03bc-receptor in chronic lymphocytic leukemia with a novel IgM-derived antibody-drug conjugate", "year": "2013"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:L7CI7m0gUJcC", "citedby": "0"}, {"bib": {"title": "OSU-2S: a novel non-immunosuppressive FTY720 derivative mediates potent cytotoxic activity through PKC dependent phosphorylation of tumor suppressor SHP1 and down modulation of \u2026", "year": "2013"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:35r97b3x0nAC", "citedby": "0"}, {"bib": {"title": "ROR1 directed delivery of FTY720 derivative OSU-2S mediates potent cytotoxic activity against chronic lymphocytic leukemia but not normal B cells in-vitro and in ROR1 \u2026", "year": "2013"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:W5xh706n7nkC", "citedby": "0"}, {"bib": {"title": "Generation of a Platform for Identification of CLL Specific Cell Surface Proteins Targeted by Anti-Tumor Antibodies in Patient Sera After Allogeneic Hematopoietic Cell \u2026", "year": "2012"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:zLWjf1WUPmwC", "citedby": "0"}, {"bib": {"title": "Engineered T cells modified with a high-affinity ROR1-CAR confer superior anti-tumor reactivity in vitro and in a mouse lymphoma model", "year": "2012"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:ILKRHgRFtOwC", "citedby": "0"}, {"bib": {"title": "Generation and use of fab, scfv, and related binding molecules specific for hiv-1 rev", "year": "2012"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:KUbvn5osdkgC", "citedby": "0"}, {"bib": {"title": "Titer, and Not Avidity Determines Degree of Pathogenicity of Anti-IFN\u03b3 Autoantibodies in Mediating Immunodeficiency", "year": "2012"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:WZBGuue-350C", "citedby": "0"}, {"bib": {"title": "Fc\u03bc-Receptor (Fc\u03bcR; TOSO/FAIM3) Mediated Internalization of Antibody-Drug Conjugates: A Novel Approach to Selectively Target Chronic Lymphocytic Leukemia \u2026", "year": "2011"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:epqYDVWIO7EC", "citedby": "0"}, {"bib": {"title": "5.21 ROR1-Immunotoxin as a Potential Therapeutic Agent for Certain Human B-cell Malignancies", "year": "2011"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:ipzZ9siozwsC", "citedby": "0"}, {"bib": {"title": "5.1 Therapeutic Potential and Challenges of Targeting Receptor Tyrosine Kinase ROR1 with Monoclonal Antibodies in CLL", "year": "2011"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:uJ-U7cs_P_0C", "citedby": "0"}, {"bib": {"title": "5.53 The Anti-Tumor Reactivity of ROR1-CAR Modified T Cells Depends on the Targeted Epitope, CAR-Affinity and Design of the CAR Extracellular Domain", "year": "2011"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:kzcrU_BdoSEC", "citedby": "0"}, {"bib": {"title": "ROR1 AS A NOVEL TARGET FOR PRE-B ACUTE LYIVIPHOBLASTIC LEUKEMIA ANI) NEUROBLASTOMA:(Poster 172)", "year": "2011"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:GFxP56DSvIMC", "citedby": "0"}, {"bib": {"title": "ROR1: A novel target for pre-B acute lymphoblastic leukemia and neuroblastoma", "year": "2011"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:LjlpjdlvIbIC", "citedby": "0"}, {"bib": {"title": "Novel Antigen-Specific Expansion of T Cells Transduced with a CD19 Chimeric Antigen Receptor", "year": "2010"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:tuHXwOkdijsC", "citedby": "0"}, {"bib": {"title": "Allogeneic Hematopoetic Transplantation for CLL: Results of Combination Chemotherapy as Pre-Transplant Targeted Lymphocyte Depletion on Disease Response, Donor Chimerism, and \u2026", "year": "2010"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:j8SEvjWlNXcC", "citedby": "0"}, {"bib": {"title": "insideblood", "year": "2010"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:JQOojiI6XY0C", "citedby": "0"}, {"bib": {"title": "CD8+ T Cells Engineered to Express a ROR1-Specific Chimeric Antigen Receptor Specifically Recognize ROR1 Positive B Cell Tumors.", "year": "2009"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:evX43VCCuoAC", "citedby": "0"}, {"bib": {"title": "Program and arm: Conferring tissue-specific cytotoxicity to Fc-drug conjugates", "year": "2009"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:p__nRnzSRKYC", "citedby": "0"}, {"bib": {"title": "AGE-ASSOCIATED INCREASE IN CANCER STEM CELLS DETECTED AS THE SIDE POPULATION IN THE NZB MODEL OF CLL", "year": "2008"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:tzM49s52ZIMC", "citedby": "0"}, {"bib": {"title": "MicroRNA miR-16 linked to the development and progression of B cell malignancies in the NZB de novo murine model of CLL", "year": "2008"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:vbGhcppDl1QC", "citedby": "0"}, {"bib": {"title": "346: Homeostatic and Inflammatory Processes Contribute to Elevated Plasma Levels of B Cell Activating Factor (BAFF) in Chronic Graft Versus Host Disease (CGVHD)", "year": "2008"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:0KyAp5RtaNEC", "citedby": "0"}, {"bib": {"title": "354: Elevated Levels of CD19+ CD21-Transitional B cells in Chronic Graft Versus Host Disease (CGVHD) Associated with Elevated Plasma BAFF Levels and BAFF Receptor Expression", "year": "2008"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:_Ybze24A_UAC", "citedby": "0"}, {"bib": {"title": "Soluble BAFF Is Elevated Following Allogeneic SCT but Is Not an Early Predictor for the Development of cGVHD.", "year": "2007"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:uLbwQdceFCQC", "citedby": "0"}, {"bib": {"title": "MEDI 110-Synthesis of a reactive linker for the construction of antibody-drug hybrid molecules", "year": "2007"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:tKAzc9rXhukC", "citedby": "0"}, {"bib": {"title": "Synthesis of the next-generation therapeutic antibodies that combine cell targeting and", "year": "2007"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:ruyezt5ZtCIC", "citedby": "0"}, {"bib": {"title": "Synthetic antibodies prey on B cells", "year": "2006"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:W7OEmFMy1HYC", "citedby": "0"}, {"bib": {"title": "Surface expression of gp96 on tumors and the maturation of tolerogenic dendritic cells", "year": "2006"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:URolC5Kub84C", "citedby": "0"}, {"bib": {"title": "Human single-chain Fv antibodies against Burkholderia mallei and Burkholderia pseudomallei.", "year": "2006"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:Ri6SYOTghG4C", "citedby": "0"}, {"bib": {"title": "Synthetic anti-BR3 antibodies that mimic BAFF binding and target both human and murine B cells. Commentary", "year": "2006"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:vDijr-p_gm4C", "citedby": "0"}, {"bib": {"title": "Phage Display: A Laboratory Manual Phage Display: A Laboratory Manual, 2001", "year": "2005"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:6ZxmRoH8BuwC", "citedby": "0"}, {"bib": {"title": "Sequences of Proteins of Immunological Interest Sequences of Proteins of Immunological Interest, 1991", "year": "2005"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:ClCfbGk0d_YC", "citedby": "0"}, {"bib": {"title": "Antibodies: A Laboratory Manual Antibodies: A Laboratory Manual, 1988", "year": "2005"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:FPJr55Dyh1AC", "citedby": "0"}, {"bib": {"title": "Simultaneous silencing of two independent signaling pathways essential for angiogenesis using bispecific, tetravalent intradiabodies", "year": "2004"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:nrtMV_XWKgEC", "citedby": "0"}, {"bib": {"title": "Simultaneous Silencing of Two Independent Signaling Pathways Essential for Angiogenesis Using Bispecific, Tetravalent Intra-Diabodies.", "year": "2004"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:t7zJ5fGR-2UC", "citedby": "0"}, {"bib": {"title": "New prodrugs of dynemicin analogs and doxorubicin analogs for selective chemotherapy mediated by an aldolase catalytic antibody.", "year": "2004"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:uWiczbcajpAC", "citedby": "0"}, {"bib": {"title": "Integrin IIb 3-specific synthetic human monoclonal antibodies and HCDR3 peptides that potently inhibit platelet aggregation", "year": "2003"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:IRz6iEL74y4C", "citedby": "0"}, {"bib": {"title": "Intra-diabodies: Bispecific, tetravalent antibodies for the simultaneous knockout of VEGF-R2 and Tie-2.", "year": "2003"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:_Re3VWB3Y0AC", "citedby": "0"}, {"bib": {"title": "Zebra stripes in the cerebellum: Identification of a neurite outgrowth related protein expressed in sagittal zones in the cerebellar cortex.", "year": "2000"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:g3aElNc5_aQC", "citedby": "0"}, {"bib": {"title": "PROTEIN STRUCTURE AND FOLDING-Generation and characterization of a recombinant human CCR5-specific antibody. A phage display approach for rabbit antibody humanization.", "year": "2000"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:4MWp96NkSFoC", "citedby": "0"}, {"bib": {"title": "From Catalytic Asymmetric Synthesis to the Transcriptional Regulation of Genes: In Vivo and In Vitro Evolution of Proteins-IV Multiple Hapten Selection: Refining the Active \u2026", "year": "2000"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:yB1At4FlUx8C", "citedby": "0"}, {"bib": {"title": "From Catalytic Asymmetric Synthesis to the Transcriptional Regulation of Genes: In Vivo and In Vitro Evolution of Proteins-III Directing Evolution at the Level of Chemical \u2026", "year": "2000"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:-_dYPAW6P2MC", "citedby": "0"}, {"bib": {"title": "From Catalytic Asymmetric Synthesis to the Transcriptional Regulation of Genes: In Vivo and In Vitro Evolution of Proteins-V Selection and Evolution of Novel DNA-Binding \u2026", "year": "2000"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:2KloaMYe4IUC", "citedby": "0"}, {"bib": {"title": "II. Biological factors that determine neuronal differentiation, axonal growth, guidance and target recognition-9-Discrete clusters of axonin-1 and NgCAM at neuronal contact \u2026", "year": "1998"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:7T2F9Uy0os0C", "citedby": "0"}, {"bib": {"title": "Structure/function Analysis of the Neural Glycoprotein Axonin-1", "year": "1995"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:BwyfMAYsbu0C", "citedby": "0"}, {"bib": {"title": "Tunable Drug Conjugates: A Differentiated Drug Conjugate (DC) Platform"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:P7Ujq4OLJYoC", "citedby": "0"}, {"bib": {"title": "Christoph Rader, PhD, National Cancer Institute/NIH"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:LhH-TYMQEocC", "citedby": "0"}, {"bib": {"title": "Department of Immunology and Microbiology"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:HeT0ZceujKMC", "citedby": "0"}, {"bib": {"title": "167 Biotechnological potential of the fungal CTG clade species in the synthetic biology era 168 Codex guideline and Food and Agriculture Organization database on low-level"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:yFnVuubrUp4C", "citedby": "0"}, {"bib": {"title": "Supplemental Material to: Sivasubramanian Baskar, Adrian Wiestner, Wyndham H."}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:0N-VGjzr574C", "citedby": "0"}, {"bib": {"title": "Notice of Retraction"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:MLfJN-KU85MC", "citedby": "0"}, {"bib": {"title": "Chemoselective Labeling of Thiols with Sulfone Reagents: A Serum-Stable Alternative to Maleimide-Based Protein Conjugation"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:fEOibwPWpKIC", "citedby": "0"}, {"bib": {"title": "Symposium1 Cancer Immunotherapy: Current Status and Future Prospects"}, "source": "citations", "id_citations": "6ebyHtoAAAAJ:VL0QpB8kHFEC", "citedby": "0"}]}